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Prospective observational and clinical trial data report a clear 
association between diabetes mellitus and vascular disease, 
which involves cerebrovascular disease. The benefits of lower-
ing blood glucose on microvascular health are well known, but 
benefits on macrovascular, especially cerebrovascular, health 
are less apparent. 
  Oh et al. [1] recently reported that an elevated glycated he-
moglobin level (5.8±0.5% vs. 5.5±0.5%, P<0.01) in non-dia-
betic Korean male adults had an association with increased 
risk for ischemic stroke. Diabetes is a known risk factor for 
cardiovascular diseases, and its relationship with the risk of 
stroke has also been reported. Previous cohort studies have 
found that diabetes nearly doubled the risk of stroke incidence 
and doubled or even quadrupled the risk of death from stroke, 
after adjustment for other risk factors [2,3]. Many cohort stud-
ies have also investigated the association between blood glu-
cose level and stroke and revealed the relationships of fasting 
blood glucose level and postprandial blood glucose level with 
stroke [4,5]. However, previous studies of fasting glucose con-
centrations and incident stroke in non-diabetic populations 
have reported mixed results [4], possibly because a single glu-
cose measurement has high intraindividual variation and is 
not a good measurement of chronic hyperglycemia, especially 
in people without overt diabetes. 
  Unlike fasting and postprandial blood glucose level, A1C is 
not affected by short-term lifestyle changes. Therefore, A1C 
can provide a more accurate glycemic status [6]. However, only 
a few trials have investigated the relationship between A1C 
and the risk of stroke incidence in the general population [7]. 
  Observational analyses of data from the United Kingdom 
Prospective Diabetes Study (UKPDS) suggested that A1C is 
positively associated with the risk of stroke, and a cohort study 
revealed that elevated A1C could be an independent risk fac-
tor for ischemic stroke in people with and without diabetes [8]. 
  Oh et al. [1] demonstrated that subjects in the highest A1C 
(A1C >6.0%) quartile showed a nearly 10-fold increased risk 
for ischemic stroke compared with those in the lowest A1C 
(5.3%<A1C≤5.6%) quartile after adjusting for confounding 
variables including age, smoking, body mass index, high den-
sity lipoprotein cholesterol, low density lipoprotein cholester-
ol, systolic and diastolic pressure. 
  However, the suggested use of A1C for evaluating the cur-
rent blood glucose level may present several disadvantages, in-
cluding the unsatisfactory correlation with fasting blood glu-
cose, the risk of overestimation among patients with iron-defi-
ciency anemia or among those predisposed to rapid glycosyl-
ation, and the underestimation in certain populations such as 
elderly persons, pregnant women, end-stage renal disease, and 
non-Hispanic blacks, people with increased red-cell turnover 
or in those with a history of alcohol abuse [9]. The potential 
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interference from hemoglobin variants is another possible dis-
advantage. Oh et al. [1] used a single baseline measurement of 
A1C and therefore cannot evaluate the effects of changes in 
this parameter over time.
  This study by Oh et al. [1] is a clinically important work 
showing A1C is a predictive value for ischemic stroke in non-
diabetic Korean male adults. These results suggest that chronic 
exposure to hyperglycemia could play a role in the develop-
ment of stroke in people without diabetes, although this study 
only included male adults and was a cross-sectional, case-con-
trolled study.
  Interestingly, smoking rate in ischemic stroke patients was 
10 times greater than that in control subjects (51.1% vs. 5.5%) 
in this study. Smoking decreased insulin-mediated glucose 
uptake and enhanced oxidative stress; these effects are sug-
gested as mechanisms in smoking-related deterioration in 
glucose metabolism [10]. 
  More large-scale, long-term prospective cohort studies di-
rectly evaluating the association of A1C and ischemic stroke 
morbidity including insulin sensitivity and insulin resistance 
in non-diabetic Korean adults are warranted. Finally, we great-
ly appreciate the effort of the study investigators to conduct 
such an important clinical study and wish them continued 
success in their future research.
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